Cresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower Products
- Cresco Labs invests in core market Florida, bringing premium quality flower and live rosin products to Sunnyside dispensaries.
- FloraCal and Cresco brands offer sought-after premium quality options for cannabis connoisseurs.
- Cresco Labs' Operations team has a proven record of expanding consistency and quality standards across markets.
- None.
Cresco Labs expanded its brand portfolio in
“We continue to invest in one of our core markets,
One of the first cannabis brands to launch in
Cresco, another decorated cannabis brand, is sold in
For more information about FloraCal, visit www.floracalfarms.com. To learn more about Cresco, visit www.crescocannabis.com.
About Cresco Labs Inc.
Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230921915523/en/
Media
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
312-953-2767
Investors
Megan Kulick, Cresco Labs
SVP, Investor Relations
investors@crescolabs.com
General Cresco Labs Inquiries
312-929-0993
info@crescolabs.com
Source: Cresco Labs